Expected earnings - Monopar Therapeutics Inc.
Source: US Earnings Reports
Monopar Therapeutics Inc. (MNPR) is expected to report $-0.47 for Q2 2025
Monopar Therapeutics Inc.
NASDAQ: MNPR
MNPR Trading
1.69% G/L:
$62.80 Last:
198,326 Volume:
$61.42 Open:
MNPR Latest News
March 02, 2026 08:00:00 am
Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer
November 13, 2025 08:00:00 am
Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments
MNPR Stock Data
$384,114,928
4,169,932
0.03%
12
N/A
Biotechnology & Life Sciences
Healthcare
US
Wilmette
